METHOD FOR MODIFYING THE THERAPEUTIC EFFECTS OF DRUGS
A method for modifying the effect of a drug by application of an activation protocol, comprising: administering a drug according to a treatment protocol; applying an activation protocol in a timed relationship to the administering, for differentially activation of at least one selected brain region; wherein the differentially activation allows the drug to selectively interact with the at least one selected brain region..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Europäisches Patentamt - (2018) vom: 28. Juni Zur Gesamtaufnahme - year:2018 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HENDLER TALMA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2018-06-28, Last update posted on www.tib.eu: 2022-10-09, Last updated: 2023-02-09 |
|---|
| Patentnummer: |
WO2018116250 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA006598145 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA006598145 | ||
| 003 | DE-627 | ||
| 005 | 20230504074927.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210531s2018 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA006598145 | ||
| 035 | |a (EPA)WO2018116250 | ||
| 035 | |a (EPA)62626290 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HENDLER TALMA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a METHOD FOR MODIFYING THE THERAPEUTIC EFFECTS OF DRUGS |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2018-06-28, Last update posted on www.tib.eu: 2022-10-09, Last updated: 2023-02-09 | ||
| 520 | |a A method for modifying the effect of a drug by application of an activation protocol, comprising: administering a drug according to a treatment protocol; applying an activation protocol in a timed relationship to the administering, for differentially activation of at least one selected brain region; wherein the differentially activation allows the drug to selectively interact with the at least one selected brain region. | ||
| 650 | 4 | |a med | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61B: Diagnosis; surgery; identification (analysing biological material g01n, e.g. g01n0033480000) | |
| 650 | 4 | |a A61N: Electrotherapy; magnetotherapy; radiation therapy; ultrasound therapy (measurement of bioelectric currents a61b;surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body a61b0018000000;anaesthetic apparatus in general a61m;incandescent lamps h01k;infra-red radiators for heating h05b) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a RAZ GAL |4 aut | |
| 700 | 0 | |a SAR-EL ROY ITZHAK |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2018) vom: 28. Juni |
| 773 | 1 | 8 | |g year:2018 |g day:28 |g month:06 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/62626290/publication/WO2018116250A1?q=WO2018116250 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | u | w | |j 2018 |b 28 |c 06 |
| 951 | |a AR | ||
| 952 | |j 2018 |b 28 |c 06 | ||